MILR1
Basic information
Region (hg38): 17:64449037-64492770
Previous symbols: [ "C17orf60" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MILR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 0 | 0 |
Variants in MILR1
This is a list of pathogenic ClinVar variants found in the MILR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-64477734-A-G | Likely benign (Jun 14, 2018) | |||
17-64477825-A-G | Uncertain significance (Aug 10, 2023) | |||
17-64477830-T-C | Uncertain significance (Mar 20, 2024) | |||
17-64477836-G-A | Uncertain significance (Jul 11, 2022) | |||
17-64477837-C-A | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 | Uncertain significance (Oct 05, 2022) | ||
17-64477846-T-C | Uncertain significance (May 21, 2024) | |||
17-64477850-C-T | Likely benign (Nov 24, 2023) | |||
17-64477852-TAATC-T | Uncertain significance (Jan 16, 2024) | |||
17-64477856-CAA-C | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 | Pathogenic (Aug 01, 2011) | ||
17-64477861-A-C | not specified | Uncertain significance (Jul 27, 2024) | ||
17-64477864-C-T | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 • Hereditary spastic paraplegia | Conflicting classifications of pathogenicity (Dec 11, 2024) | ||
17-64477880-A-G | Likely benign (Nov 17, 2023) | |||
17-64477881-T-A | Uncertain significance (Oct 08, 2024) | |||
17-64477883-C-T | Uncertain significance (Mar 06, 2024) | |||
17-64477895-C-T | Uncertain significance (Oct 28, 2024) | |||
17-64477897-T-C | Uncertain significance (Oct 09, 2024) | |||
17-64477900-T-C | Uncertain significance (Oct 13, 2024) | |||
17-64477904-G-A | Likely benign (Apr 06, 2024) | |||
17-64477916-C-A | Likely benign (Jan 26, 2022) | |||
17-64477918-G-T | Hereditary spastic paraplegia | Uncertain significance (Feb 14, 2023) | ||
17-64477920-TG-T | Uncertain significance (Jun 09, 2024) | |||
17-64477929-C-T | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 • POLG2-related disorder | Likely pathogenic (Nov 01, 2024) | ||
17-64477930-C-G | Uncertain significance (May 02, 2023) | |||
17-64477932-T-G | Uncertain significance (Nov 18, 2024) | |||
17-64477933-TCTCCA-T | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 | Uncertain significance (Oct 11, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MILR1 | protein_coding | protein_coding | ENST00000605096 | 4 | 3192 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0245 | 0.792 | 120418 | 13 | 590 | 121021 | 0.00249 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.540 | 36 | 46.3 | 0.777 | 0.00000233 | 569 |
Missense in Polyphen | 12 | 12.952 | 0.92652 | 139 | ||
Synonymous | 1.09 | 11 | 16.7 | 0.660 | 8.98e-7 | 161 |
Loss of Function | 0.984 | 3 | 5.49 | 0.547 | 2.30e-7 | 75 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000126 | 0.000126 |
Ashkenazi Jewish | 0.000628 | 0.000609 |
East Asian | 0.000120 | 0.000114 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000389 | 0.0000365 |
Middle Eastern | 0.000120 | 0.000114 |
South Asian | 0.0215 | 0.0200 |
Other | 0.00107 | 0.00102 |
dbNSFP
Source:
- Function
- FUNCTION: Immunoglobulin-like receptor which plays an inhibitory role in degranulation of mast cells. Negatively regulates IgE- mediated mast cell activation and suppresses the type I immediate hypersensitivity reaction (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0719
Haploinsufficiency Scores
- pHI
- 0.0418
- hipred
- hipred_score
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Mouse Genome Informatics
- Gene name
- Milr1
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- negative regulation of mast cell activation;mast cell degranulation
- Cellular component
- integral component of plasma membrane;mast cell granule
- Molecular function